Search
for
Sort by
Research 511–540 of 1000+
- Alopecia Areata Treatment Patterns and Satisfaction: Results of a Real-World Cross-Sectional Survey in Europe
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- Adverse events associated with aromatase inhibitors: an analysis of real-world datasets and drug-gene interaction network
- Long-term live imaging of the<i>Drosophila</i>adult midgut reveals real-time dynamics of cell division, differentiation, and loss
- Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
- Effectiveness and Safety of Topical Finasteride for Male Androgenetic Alopecia: Real World Data
- Ritlecitinib Efficacy in Adolescents With Alopecia Areata: A Real‐World Experience
- Increased risk of hair loss with GLP-1 receptor agonists: A real-world multicenter TrinetX cohort study
- Effectiveness of baricitinib in severe alopecia areata in real life: a retrospective study of 87 patients.
- Effectiveness of baricitinib in severe alopecia areata in real life
- Long‐Term Use of Tralokinumab in Patients With Atopic Dermatitis: A Real‐World Multicentric Case Series
- Clascoterone Cream 1% in Acne Management: Case Series and Real-World Canadian Experience
- Multidimensional assessment of adverse events of finasteride:a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- 272 Dupilumab treatment in children with alopecia areata: A real-world, single-center observational study
- Work motivation and personal adaptation potential of specialists in the real estate field
- Alopecia prevention during chemotherapy: from the benchmark to real clinical practice. A prospective study
- A description of alopecia areata in European patients based on real-world survey data: physician-reported characterization of severity and associated treatment utilization
- Application of the waiting time distribution in a nationwide screening of real‐world dermatology drug utilization for aberrant use patterns
- Image3_Neuropsychiatric Adverse Events of Montelukast: An Analysis of Real-World Datasets and drug−gene Interaction Network.TIFF
- 26021 Delivering care for the underserved during COVID-19 through real-time teledermatology, a cross-sectional review of patients at a student-run free clinic in Dallas
- Low‐dose oral minoxidil in female patients with lichen planopilaris: Real‐life experience
- Mesotherapy With Dutasteride for Androgenetic Alopecia: A Retrospective Study in Real Clinical Practice.
- Sexual adverse events-related to dutasteride e finasteride: analysis of real-life data from Eudra-Vigilance database
- The mineralocorticoid receptor as a novel player in skin biology: beyond the renal horizon?
- Finasteride Reduces Microvessel Density and Expression of Vascular Endothelial Growth Factor in Renal Tissue of Diabetic Rats
- Low serum testosterone is associated with an increased risk of first-time renal calculi in men without testosterone replacement therapy
- A case of simultaneous onset of highly active systemic lupus erythematosus and IgG4-related renal disease
- The safety profiles of avacopan on microscopic polyangiitis and granulomatosis with polyangiitis: a real-world pharmacovigilance analysis
- Hormonal manipulation with finasteride or oral contraception does not influence incidence of renal cell carcinoma
- Association of long-term 5α-reductase inhibitor use with survival in men with renal cell carcinoma: a nationwide population-based cohort study